The Independent on MSN10d
GSK shares jump after landmark £1.68bn heartburn drug settlementThe pharmaceutical giant has settled the vast majority of cases around its drug Zantac in the US, boosting investor ...
Shares in drugmaker GSK surged on Thursday after it struck a 2.2 billion US dollar (£1.68 billion) settlement to resolve tens of thousands of lawsuits in the US over its discontinued heartburn drug ...
The product reduces the amount of acid the stomach makes, and was a best-seller in the UK and US in the early 1980s in treating indigestion, heartburn and acid reflux. It was the first drug to ...
Shares in GSK have jumped after a settlement with heart drug users in the US (Andy Buchanan/PA) Shares in drugmaker GSK surged on Thursday after it struck a 2.2 billion US dollar (£1.68 billion ...
Dr Ahmed, a GP based in the UK, took to TikTok to issue the warning, saying: "I bet the vast majority of you have even been ...
Investopedia on MSN10d
GSK Stock Jumps as UK Drug Giant Resolves Most US Zantac LawsuitsGSK shares in London jumped 5% Thursday after the British drug giant said it has resolved most of the U.S. lawsuits it faced ...
A prominent legal firm in Australia, Shine Lawyers, is exploring a potential class action against makers of common heartburn drugs, for failing to disclose the long-term health risks associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback